文献速递皮肤肿瘤

荷兰全国性研究:首发与多发性基底细胞癌的发病率、趋势及未来发病预测

A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence.
PubMed 文献 · Br J Dermatol · 2021-12-27

基于荷兰癌症登记系统2001-2019年全国组织病理学确诊基底细胞癌数据,共601 806例首发患者。男女年龄标化发病率分别从157升至304/10万人年和124升至274/10万人年。30-39岁男女年发病率分别下降3.6%和3.0%,50岁及以上持续上升。四分之一首发患者在3年内发生后续基底细胞癌,预计未来10年男性增30.4%、女性增25.3%。

要点

  • 过去二十年基底细胞癌发病率翻倍,50岁及以上人群仍持续上升。
  • 30-39岁男女年发病率分别下降3.6%和3.0%,近期趋势似趋稳定。
  • 四分之一首发患者在3年内发生一个或多个后续基底细胞癌。

核心结论

  • 基底细胞癌发病率在过去二十年翻倍,50岁以下患者趋势似趋稳定,50岁及以上持续上升,未来十年预计进一步增加。

研究设计与样本

  • 基于荷兰癌症登记系统的全国性人群研究,纳入2001-2019年组织病理学确诊的基底细胞癌患者,共601 806例首发患者。
  • 采用年龄标化发病率、估计年度百分比变化分析趋势,并用回归模型预测至2029年发病率。

主要发现

  • 男性首发基底细胞癌年龄标化发病率从157升至304/10万人年,女性从124升至274/10万人年。
  • 30-39岁男性年发病率下降3.6%,女性下降3.0%。
  • 50岁及以上患者呈持续上升趋势。
  • 四分之一首发原发性基底细胞癌患者在3年内发生一个或多个后续基底细胞癌。
  • 未来10年预计男性发病率增加30.4%,女性增加25.3%。

临床怎么用

  • 作者认为50岁以下患者趋势趋稳定可能是发病下降的初步迹象,50岁及以上发病率持续上升,未来十年预计进一步增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Basal cell carcinoma (BCC) is the most frequently diagnosed malignancy worldwide and an ever increasing annual incidence is observed. However, nationwide registries of BCCs are very rare, and often extrapolation of the data has been necessary to estimate the absolute number of diagnoses. As of September 2016, all histopathologically confirmed BCCs are registered in the Netherlands, due to developments in automatic notification and import in the Netherlands Cancer Registry. This offers the unique possibility to assess the nationwide population-based incidence of first and multiple BCCs. OBJECTIVES: To assess the nationwide incidence and trends of first and multiple BCCs in the Netherlands and to predict incidence rates up to 2029. METHODS: All patients with histopathologically confirmed BCC between 2001 and 2019 were selected from the population-based Netherlands Cancer Registry. Age-standardized incidence rates were calculated and trends were analysed with use of the estimated annual percentage change. Prediction of BCC incidence rates up to 2029 was based on a regression model. RESULTS: In total, 601 806 patients were diagnosed with a first BCC over the period 2001-2019. The age-standardized incidence rates for both men and women with a first BCC increased over these years, from 157 to 304 and from 124 to 274 per 100 000 person-years, respectively. For male and female patients aged 30-39 years, decreases in annual incidences of -3·6% and -3·0%, respectively, were found in recent years. For patients aged 50 years or older an ever increasing trend was found. One-quarter of the patients with a first primary BCC developed one or more subsequent BCCs within 3 years. Increases in incidence of 30·4% (male) and 25·3% (female) are expected in the next 10 years. CONCLUSIONS: BCC incidence has doubled over the past two decades. Trends have seemed to stabilize in recent years for patients aged < 50 years. This might be a first sign of a decreasing trend. The incidence continues to rise in patients aged 50 years and older. In the next decade a further increase in BCC incidence is expected.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Schreuder K, Hollestein L, Nijsten TEC, et al. A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence. Br J Dermatol. 2021. PMID: 34726263. doi:10.1111/bjd.20871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。